Amorepacific Corporation

Jeong-kee Kim

Yong-Deog Hong

Si Young Cho

Minsik Choi

Bumjin Lee

Hyun Woo Jeong

Juyeon Seo

Ayoung Kim

Jinoh Chung

Yeonsu Jeong

A Young Kim

The present disclosure relates to a composition for ameliorating a circulatory system disease, which contains a green tea extract with modified ingredient content. According to the present disclosure, it is possible to effectively prevent, ameliorate and treat circulatory system diseases without side effects and, thereby, to greatly help patients with circulatory system diseases and contribute to the development of related industries.

Composition for ameliorating circulatory system diseases, comprising tea extract with modified ingredients content

Disclosed in the present application are: a composition containing a green tea extract comprising at least one selected from the group consisting of 7 wt % or more of polysaccharides, less than 20 wt % of catechins, and 10 wt % or more of dietary fibers, relative to a total weight of the green tea extract, the composition having a use for blood glucose control; and a method for preparing the composition. The composition has not only effects of inhibiting activity of glucosidase and amylase but also effects of lowering blood glucose by inhibiting the glucose uptake in small intestinal cells.

Composition containing, as active ingredient, green tea extract with increased polysaccharide content

The present specification relates to a whitening composition containing a novel quercetin-based compound isolated from post-fermented tea, an isomer thereof, a pharmaceutically acceptable salt thereof, a hydrate thereof, or a solvate thereof, wherein the whitening composition can be widely utilized in fields associated with skin whitening and skin care.

Whitening composition containing novel quercetin-based compound

The present specification relates to a composition containing a tea extract with an increased specific ingredient content for prevention or alleviation of lipid metabolism disorders. The use of a preparation method and a composition according to the present specification can effectively prevent and treat lipid metabolism disorders including obesity without side effects, thereby meeting related demands and promoting the development of corresponding industries.

Method for preventing or alleviating lipid metabolism disorders using composition containing green tea extract with increased specific ingredient content

The present specification relates to an anti-inflammatory composition including a novel compound isolated from a post-fermented tea, an isomer thereof, a pharmaceutically acceptable salt thereof, a hydrate thereof, or a solvate thereof, and may be widely used in various areas related to anti-inflammation.

Anti-inflammatory composition including novel kaempferol-based compound derived from post-fermented tea

The present specification relates to an anti-inflammatory composition including a novel quercetin-based compound isolated from a post-fermented tea, an isomer thereof, a pharmaceutically acceptable salt thereof, a hydrate thereof, or a solvate thereof, and may be widely used in various areas related to anti-inflammation.

Anti-inflammatory composition including novel quercetin-based compound

The present specification relates to a novel compound separated from post fermented tea, an isomer thereof, a pharmaceutically acceptable salt thereof, a hydrate thereof, or a solvate thereof, the compound being capable of being widely used in post fermented tea-related industries and various fields in which the compound may be used.

Post fermented tea-derived kaempferol-based compound

The present specification relates to a whitening composition including a novel compound isolated from a post-fermented tea, an isomer thereof, a pharmaceutically acceptable salt thereof, a hydrate thereof, or a solvate thereof, and may be widely used in various areas related to skin whitening and skin care.

Whitening composition including novel kaempferol-based compound derived from post-fermented tea

The present specification relates to a novel quercetin-based compound separated from post fermented tea, an isomer thereof, a pharmaceutically acceptable salt thereof, a hydrate thereof or a solvate thereof, the compound being capable of being widely used in post fermented tea-related industries and various fields in which the compound may be used.

Growing community of inventors

Yongin-si, South Korea

Jeong-kee Kim